Established patient returns to the triage clinic for redness/swelling of adnexa
 
CC: red/swolling/irritated OS, adexa and globe; adnexa is red/swollen and tender 
to touch of LUL and LLL; globe is mildly red; all started yesterday; Denies any 
recent illnesses/trauma

Patient also reports that room seems a little dimmer OD/OS - has been going on 
for the past year - denies a dimming/blackening that occurs and then vision 
comes back, appears to be more lighting dependent, says everything appears 
normal in bright lighting, just with dimmer lighting everything appears dimmer 
than usual 
 
The patient was last seen 01/29/16 for complete by Dr. Munther

The patient is being followed for:
1. Refractive error (with no previous refraction at the VA)

OCULAR HX: 
  Pain/Discomfort Scale 1/10: 0 
  [-] Trauma: 
  [-] Surgery: 
  [-] Strabismus: 
  [-] Glaucoma: 
  [-] Flashes:
  [-] Floaters: 
  [-] Diplopia: 
        Other: 
 
Ocular meds: none

FAM. OC HX: 
  [-]Glaucoma    [-]Macular Degeneration 
  [-]Blindness   [-]Retinal Detachment 
     Other: 
 
MED HX: 
(-)DM 
(-)HTN 
(-)Hyperlipidemia 
(-)CVA 
(-)Cancer 
(-)Hepatic
(-)Renal 
(+)Cardiovascular:              Anemia
(-)Respiratory
(-)Neurological
(-)Genitourinary 
(-)Hematologic
(+)Endocrine:                   Hypothyroid
(-)Musculoskeletal
(-)Autoimmune
(-)Gastrointestinal
(+)Psychiatric:                 schizophrenia
(+)Other:                       Vitamin D deficiency, Herpes Simplex
                                History of noncompliance with medication regimen
                                Reports history of shingles around eye 

PSHX:
(-)Smoke
(-)ETOH 

Current Medications Reviewed
Allergies - ASPIRIN
 
CURRENT SPECTACLE RX: 
  OD: +2.75 -1.00 x 159 
  OS: +3.00 sphere 
  ADD: +1.50 

VISUAL ACUITY: With Correction (through last MRx) 
         DIST 
 OD: 20/40
 OS: 20/30

EOM: Smooth and full w/o Diplopia/Pain 
PUPILS: PERRL: Yes; No APD OD/OS
 
REFRACTION AND BEST VISUAL ACUITY: 
  OD:  +3.50 -1.00 x 151        20/30+2
  OS:  +2.75 sph                20/25+2
  ADD: +1.50, but pt reports no improvement in VA with Add (20/60 OS, 20/30 OU)

Patient prefers
[+]Line bifocal
[+]UV400
[+]Scratch coating
[+]Tint at patient's preference

**variable refraction, patient denies changes to vision with large dioptic steps 
**Requires frequent encouraging, occasional would see patient closing 
eyes/almost sleeping behind phoropter, may benefit from trial frame refraction 
in the future

SLIT LAMP EXAM: 
   Lids/Lashes: 
        OD: normal
        OS: gr1+ edema with mild redness LUL and LLL 
   Sclera/Conjunctiva: 
        OD: tr papillae 
        OS: gr2 diffuse follicles inf palp conj  (concentrated temporally)
            gr2 diffuse bulbar injection 
   Cornea: 
        OD: gr3 diffuse SPK concentrated inferiorly and coallesqued into 
                sections temporal and superiorly
        OS: gr1+ inf diffuse SPK 
 
ANTERIOR CHAMBER: 
  OD: Deep/Dark/Quiet, no cells/flare, VH 4x4 
  OS: Deep/Dark/Quiet, no cells/flare, VH 4x4 
 
IRIS: 
  OD: Flat and Intact, No Rubeosis 
  OS: Flat and Intact, No Rubeosis 
 
TONOMETRY: 
  OD: 15
  OS: 15
   TIME: 1517 

DILATION: 
  1 GTT Tropicamide (1.0%) OU 
  1 GTT Phenylephrine (2.5%) OU 
 
INTERNAL (78, 20D BIO): 

LENS: 
  OD: clear 
  OS: clear
 
VITREOUS: 
  OD: clear
  OS: clear
 
*unsteady fixation
NERVE: 
  OD: 0.40/0.45 cup/disc ratio (horiz/vert) 
      Normal Color/Margins 
  OS: 0.45/0.45 cup/disc ratio (horiz/vert)
      Normal Color/Margins 

*unsteady fixation
MACULA: 
  OD: no blood, fluid or exudates
  OS: no blood, fluid or exudates
 
*unsteady fixation
BLOOD VESSELS: 
  OD: normal course and caliber
  OS: normal course and caliber

*unsteady fixation
PERIPHERY: 
  OD: No holes, tears or detachments 
  OS: No holes, tears or detachments

ADDITIONAL TESTS: **tested due to reduced visual acuity today**

 (+) OCT: RNFL Thickness Average Analysis Report 
           OD: Ave 90um, all quadrants/clock hours green
           OS: Ave 103um, all quadrants/clock hours green 
        -Impression: baseline, normal

 (+) OCT: Macular Thickness Report 
           OD: CT 223um, normal foveal contour, no IRF/SRF
           OS: CT 220um, normal foveal contour, no IRF/SRF
        -Impression: baseline, normal 


ASSESSMENT: 
1.  Viral conjunctivitis OS - new problem, additional workup required
        - Clear cornea with mild superficial punctate keratitis
        - No anterior chamber reaction
2.  Refractive error with Hyperopic astigmatism OD and Hyperopia OS - 
established problem, stable
        - Patient will likely benefit from trial frame refractions 
        - Best corrected visual acuity 20/30+2 OD, 20/25+2 OS
        - Patient motivation is a key contributing factor in exams
3.  Dry eye syndrome OU - new problem, additional workup required
        - Superficial punctate keratitis OD>>OS
4.  Unremarkable posterior segment health OU - established problem, stable
        - OCT shows healthy nerve fiber layer and macular findings OD/OS

PLAN:
1.  Educated patient on condition and effects on vision/ocular comfort. 
Dispensed from omnicell Tobradex for use QID OU for 1 week. Instructed patient 
to shake well before each use. Patient was requesting acyclovir for infection as 
well as a viral culture, educated patient that infection is likely not of a 
herpetic origin. Instructed patient to return to clinic in 5 days for anterior 
chamber check or sooner if vision/condition worsens or new symptoms develop. 
Monitor 1 week. 
2.  Educated patient on stability of condition and recommended specs for full 
time wear. Educated about adaptation to new specs. Due to history of variable 
refractions, patient will likely benefit from trial frame refraction in the 
future. Dispensed hard copy of prescription for patient to fill outside the VA 
if desired. Monitor yearly.
3.  Educated patient on condition and effects of unstable tear film on vision. 
No artificial tears prescribed at this time due to #1. Consider prescribing at 
anterior segment follow-up in 1 week. Monitor sooner if condition worsens. 
4.  Educated patient on stability of condition and emphasized the importance of 
yearly dilated eye exams. Monitor 1 year.

RTC 12/06/17 for anterior segment evaluation for #1 and #3.